Cancer Drug Delivery
Overview
Cancer Drug Delivery is a scientific journal, published since 1983 in English. The journal's country of origin is United States and its primary focus areas are oncology and pharmacology.
Details
Details
Abbr.
Cancer Drug Deliv
Start
1983
End
1988
Frequency
Quarterly
p-ISSN
0732-9482
Country
United States
Language
English
Specialties
Oncology
Pharmacology
Pharmacology
Recent Articles
1.
Grunberg S, Bertram J, McDermed J, Apuzzo M
Cancer Drug Deliv
. 1987 Jan;
4(1):47-53.
PMID: 3607722
Although cisplatin may have intrinsic activity against astrocytoma, limited penetration into the central nervous system may severely curtail delivery of adequate amounts of drug to the tumor. In an attempt...
2.
Wright K, Wallace S, Benjamin R, DODD Jr G
Cancer Drug Deliv
. 1987 Jan;
4(1):33-41.
PMID: 3607721
Adult mongrel dogs were used to compare hepatic arterial infusion and arterial occlusion-infusion with regard to local and systemic Adriamycin levels. The drug was infused into the right proper hepatic...
3.
Pacini A, Maioli E, Bocci V, Pessina G
Cancer Drug Deliv
. 1987 Jan;
4(1):17-23.
PMID: 3607720
Since clinical trials with TNF as a therapeutic agent for cancer are in progress, in this study we have chosen to compare the metabolic characteristics of 125I-labeled and unlabeled RTNF...
4.
Chitnis M, Pradhan S, Satyamoorthy K, Basrur V
Cancer Drug Deliv
. 1987 Jan;
4(1):1-9.
PMID: 3607719
Attempts were made to reverse the acquired resistance of P388 murine leukemia utilizing non-toxic concentration of nitroxazepine hydrochloride, an antidepressant. The effect of nitroxazepine hydrochloride on the intracellular accumulation of...
5.
Hertler A, Spitler L, Frankel A
Cancer Drug Deliv
. 1987 Jan;
4(4):245-53.
PMID: 3502618
Immunotoxins, hybrid molecules consisting of a monoclonal antibody linked to a polypeptide toxin have shown anti-tumor activity in both animal models and early clinical trials. However, their potential value in...
6.
Bore P, Iliadis A, Catalin J, Just S, Cano J
Cancer Drug Deliv
. 1987 Jan;
4(3):177-83.
PMID: 3502454
Methotrexate was administered by IV infusion, 2g (1.19 +/- 0.05 g/m2) over 24 hours, to a homogeneous group of patients undergoing treatment for breast cancer. Three courses were given at...
7.
Harkonen S, Mischak R, Lopez H, Stoudemire J
Cancer Drug Deliv
. 1987 Jan;
4(3):151-7.
PMID: 3502453
This study was performed to determine the effect of treatment with cyclophosphamide (CY) on the formation of antimurine and anti-ricin A chain antibodies in rats treated with a murine monoclonal...
8.
Dinndorf P, Bleyer W
Cancer Drug Deliv
. 1987 Jan;
4(2):105-17.
PMID: 3480777
At the time of analysis, the first 30 patients with Ommaya reservoirs (OR) at the Children's Orthopedic Hospital and Medical Center in Seattle, Washington had had 32 reservoirs for a...
9.
Nayar R, Morikawa K, Fidler I
Cancer Drug Deliv
. 1987 Jan;
4(4):233-44.
PMID: 3454250
The purpose of these studies was to characterize liposomes containing the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) and to examine their interaction with mouse peritoneal macrophages. Because of its hydrophobic properties, FMLP...
10.
Kar R, OPFELL R, Wile A
Cancer Drug Deliv
. 1987 Jan;
4(4):225-32.
PMID: 3454249
The pharmacology of hepatic regional administration of CisplatinR (DDP) was examined in a rabbit model. Routes and modes of administration were: IV, hepatic arterial infusion (HAI), HAI with stopflow, HAI...